Human parvovirus B19.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000635:transmission / Q000821:virology; D016731:Erythema Infectiosum / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D016867:Immunocompromised Host; D010322:Parvoviridae Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D016732:Parvovirus B19, Human; D012008:Recurrence
D000998:Antiviral Agents